We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 101.60
Bid: 100.20
Ask: 101.60
Change: -0.20 (-0.20%)
Spread: 1.40 (1.397%)
Open: 100.80
High: 104.20
Low: 100.20
Prev. Close: 101.80
PZC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

13 Apr 2023 07:00

RNS Number : 0400W
PZ CUSSONS PLC
13 April 2023
 

13 April 2023

 

Sixth consecutive quarter of revenue growth - strength and depth of portfolio driving performance

 

PZ Cussons plc today issues a trading update for its third quarter, ended 4 March 2023.

 

Group Summary [1]

 

· Q3 LFL revenue growth of 6.2%, in line with year-to-date performance

· Europe & the Americas region back to strong revenue growth and with significantly improved margin

· Progress against strategy to grow Must Win Brands including:

- Launching Morning Fresh into the adjacent auto-dishwash category in Australia; and

- Childs Farm performing well with the recent launch of SlumberTime innovation

· Expect FY23 adjusted profit before tax to be at least in line with current market estimates [2]

 

Revenue

Q3

YTD

£m

LFL %

LFL %

Europe & the Americas

49.3

9.9%

(1.2)%

Asia Pacific

47.6

1.0%

5.3%

Africa

68.4

7.7%

12.6%

Group [3]

166.0

6.2%

6.1%

 

Jonathan Myers, Chief Executive Officer, said:

 

"We have delivered another quarter of mid-single digit revenue growth, in line with our longer-term ambition. This represents a sixth consecutive quarter of growth, with the business underpinned by the strength and depth of our portfolio and our ongoing strategy to invest behind our brands, build internal capabilities and serve consumers better.

 

As anticipated, performance has strengthened in Europe & the Americas, with a return to revenue growth and a marked improvement in profitability in the quarter. As a result, we remain confident in delivering against FY23 expectations and that further strategic progress will be made in the balance of FY23 and into FY24."

Performance commentary

Group Q3 like for like revenue growth of 6.2% was driven primarily by price/mix improvements. Reported revenue growth was 13.5%, reflecting the full period contribution of Childs Farm which was acquired in March 2022 as well as favourable foreign exchange movements. Year to date, revenue has grown by 6.1% on a LFL basis.

 

As anticipated, performance in Europe & the Americas improved significantly in Q3. This was a result of our strategic focus on innovation and marketing, with particularly strong performances from St. Tropez US and the combined Imperial Leather and Cussons Creations portfolio. Carex revenue declined in Q3 reflecting the reduction in the UK Hand Hygiene category more broadly. Childs Farm is performing as expected and is on track for double-digit revenue growth in FY23, on a pro-forma basis.

 

Asia Pacific performance has been driven by strong growth in Australia, reflecting continued successful Revenue Growth Management activity and sustained share gains across our major brands. We recently launched Morning Fresh into the auto-dishwash category, leveraging its brand strength with a 50% share in washing-up liquid. In Indonesia, Cussons Baby revenue declined slightly, in line with the overall category, reflecting increased pressure on consumer spending in recent months as well as some retailer de-stocking.

 

Africa trading continues in line with our expectations, with all Must Win Brands in good growth. Strong trading throughout December and January was partly offset by disrupted demand in Nigeria in February due to bank note changes and the elections. These disruptions have largely dissipated and we are now seeing a return to more normal demand patterns.

 

Outlook

 

Although we remain alert to ongoing external volatility, we continue to expect FY23 adjusted profit before tax to be at least in line with current market expectations. This includes a 3-4% benefit, compared to FY22, due to the translation of results of our overseas operations.

 

Reporting calendar

 

PZ Cussons will issue a brief update on trading following the end of the financial year.

 

PZ Cussons will host a Childs Farm 'deep-dive' event for analysts and institutional investors on 4 July. The event will be led by Sarah Pollard, Chief Financial Officer, and will include presentations from Paul Yocum, Managing Director of Business Development, and Andrew Geoghegan, Chief Marketing Transformation Officer.

 

Conference call

 

PZ Cussons management will host a call for analysts and institutional investors today at 08:00 UK time.

 

Dial in details are as follows:

+44 20 3936 2999/ +44 808 189 0158

Access Code: 395221

 

 

 

Contact details

 

Investors 

Simon Whittington - IR and Corporate Development Director

+44 (0) 77 1137 2928

Media

Headland PZCussons@headlandconsultancy.com

+44 (0) 20 3805 4822

Susanna Voyle, Stephen Malthouse, Charlie Twigg

Notes to Editors

Unless otherwise stated, all references to revenue growth are on a like for like ('LFL') basis. See definitions provided in the interim results announcement for further details.

 

About PZ Cussons

 

PZ Cussons is a FTSE250 listed consumer goods business, headquartered in Manchester, UK. We employ nearly 3,000 people across our operations in Europe, North America, Asia-Pacific and Africa. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. Across our core categories of Hygiene, Baby and Beauty, our trusted and well-loved brands include Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa and St. Tropez. Sustainability and the wellbeing of our employees and communities everywhere are at the heart of our business model and strategy, and captured by our purpose: For everyone, for life, for good.

 

Cautionary note regarding forward-looking statements

 

This announcement contains certain forward-looking statements relating to expected or anticipated results, performance or events. Such statements are subject to normal risks associated with the uncertainties in our business, supply chain and consumer demand along with risks associated with macro-economic, political and social factors in the markets in which we operate. Whilst we believe that the expectations reflected herein are reasonable based on the information we have as at the date of this announcement, actual outcomes may vary significantly owing to factors outside the control of the Group, such as cost of materials or demand for our products, or within our control such as our investment decisions, allocation of resources or changes to our plans or strategy. The Group expressly disclaims any obligation to revise forward-looking statements made in this or other announcements to reflect changes in our expectations or circumstances. No reliance may be placed on the forward- looking statements contained within this announcement.

 

 


[1] Unless otherwise stated all references to revenue growth are on a like for like ('LFL') basis

[2] Bloomberg consensus of £68.1 million as at 11 April 2023

[3] Excludes 'Other' revenue of £0.7 million in Q3

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUVKROBUSAAR
Date   Source Headline
24th Apr 20247:00 amRNSQ3 Trading and update on strategic actions
19th Apr 20248:49 amRNSDirector/PDMR Shareholding
12th Apr 202411:04 amRNSDirector/PDMR Shareholding
8th Apr 20245:29 pmRNSDirector/PDMR Shareholding
19th Mar 202410:30 amRNSDirector/PDMR Shareholding
23rd Feb 20243:47 pmRNSDirector/PDMR Shareholding
19th Feb 20243:18 pmRNSDirector/PDMR Shareholding
8th Feb 20243:40 pmRNSDirector/PDMR Shareholding
8th Feb 20243:09 pmRNSDirector/PDMR Shareholding
8th Feb 20243:07 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNS2024 Interim Results
19th Jan 202410:50 amRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSDirectorate Change
18th Dec 20233:10 pmRNSDirector/PDMR Shareholding
4th Dec 20233:03 pmRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirectorate Change
29th Nov 202312:10 pmRNSDirector/PDMR Shareholding
29th Nov 202312:08 pmRNSDirector/PDMR Shareholding
23rd Nov 20235:57 pmRNSResult of AGM
23rd Nov 20237:00 amRNSAGM Trading Statement
20th Nov 20231:58 pmRNSDirector/PDMR Shareholding
19th Oct 202310:00 amRNSDirector/PDMR Shareholding
10th Oct 202311:10 amRNSDirector/PDMR Shareholding
5th Oct 20233:44 pmRNSHolding(s) in Company
27th Sep 202310:00 amRNSPreliminary Results - Correction
26th Sep 20237:00 amRNSPZ Cussons Preliminary Results
20th Sep 202311:09 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSAcquisition of minority ownership of PZCN Plc
21st Aug 20232:07 pmRNSDirector/PDMR Shareholding
26th Jul 20239:22 amRNSDirector/PDMR Shareholding
19th Jul 202310:23 amRNSDirector/PDMR Shareholding
11th Jul 20232:06 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSCapital Markets Event
30th Jun 20232:18 pmRNSDirector/PDMR Shareholding
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.